03/13
Headlines

Recro Pharma

Healthcare Watch list: Biocept Inc (NASDAQ:BIOC), Recro Pharma Inc (NASDAQ:REPH), Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Trevena Inc (NASDAQ:TRVN)

Colin Pettis02 mins

Biocept Inc (NASDAQ:BIOC) has appointed Raaj Trivedi as vice president of commercial operations. Biocept Inc (NASDAQ:BIOC) stock performance was -9.62% in last session and finished the day at $6.39. Traded volume was 24,173.00million shares in the last session and the average volume of the stock remained 47.03K shares. Biocept Inc (NASDAQ:BIOC) insider ownership is 0.40%….

Read More

Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Chris Lewis02 mins

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded…

Read More

Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Jason Knox02 mins

Recro Pharma, Inc. (NASDAQ:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today announced the appointments of Alfred F. Altomari and Dr. Michael Berelowitz to the Company’s Board of Directors. Recro Pharma Inc (NASDAQ:REPH) stock performance was 1.95% in last session and finished the day at $7.32. Traded volume was 35,553.00million…

Read More